Dec 15, 2014 at 10:10 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, pharma sector will be getting astrological support and advises buying Glenmark Pharma, Aurobindo Pharma, Dr Reddy's Labs, Divis Labs, Biocon, Cadila Healthcare, Torrent Pharma and Ipca Labs.
Dec 11, 2014 at 08:37 | Source: Moneycontrol.com
Aurobindo Pharma at its meeting held on December 10, 2014, have resolved subject to the approval of the members of the Company in terms of the provisions of the Companies Act, 2013 and of other applicable laws, regulations etc., issuance of Equity Shares through a QIP to Qualified Institutional Buyers as per the SEBl (ICDR) Regulations.
Dec 10, 2014 at 10:55 | Source: CNBC-TV18
According to Sudarshan Sukhani of s2analytics.com, one may see lower levels in Arvind.
Dec 10, 2014 at 09:50 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma and Havells India.
Dec 10, 2014 at 09:04 | Source: CNBC-TV18
HPCL too the short-term trend is up and so one can look at buying it on dips, he adds. Larsen and Toubro is a positional trade buy, so one can look for small rallies to sell it.
Dec 08, 2014 at 08:24 | Source: CNBC-TV18
Infosys | Maruti Suzuki | ONGC | ICICI Bank | SpiceJet | Coal India | SAIL | NHPC | Aurobindo Pharma | SJVN | Thermax | Jubilant Foodworks | JBF Industries | Tourism Finance and Atul Auto are stocks, which are in the news today.
Dec 05, 2014 at 19:16 | Source: PTI
The company had emerged as the highest bidder to acquire assets of Natrol under the auction process by the United States Bankruptcy Court for the District of Delaware.
Dec 05, 2014 at 16:30 | Source: Moneycontrol.com
Aurobindo Pharma today announced the completion of acquisition of assets of nutritional supplement maker, Natrol Inc. and other affiliate entities through its wholly owned subsidiary Aurobindo Pharma USA Inc.
Dec 02, 2014 at 09:44 | Source: CNBC-TV18
Rahul Mohindar of viratechindia.com recommends buying Aurobindo Pharma with a target of Rs 1175.
Dec 02, 2014 at 08:34 | Source: CNBC-TV18
Rahul Mohindar viratechindia.com like Aurobindo Pharma as a long-term bet.